Rehabilitation Post Lumbar Microdiscectomy

Low Back Disorder Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00306423
• Other study ID #: #025027
• Status: Completed
• Phase: Phase 1
• First received: March 21, 2006
• Last updated: March 30, 2017
• Start date: June 2003
• Est. completion date: August 2014

Study information

• Verified date: March 2017
• Source: University of Southern California
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether a rehabilitation program following lumbar microdiscectomy influences short-term (4 months) and long-term (up to 5 years)outcomes in quality of life, activity and endurance.

Description:

Exercise

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: August 2014
• Est. primary completion date: August 2011
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• 18-60 years old

• Single level lumbar microdiscectomy

Exclusion Criteria:

• Potential subjects will be excluded is they exhibit symptoms suggestive of facet arthrosis or neurogenic claudication, or if their plain radiographs showed more than 50 percent loss of disc height at the relevant level.

• Patients in whom the protrusion occupied more than 50 percent of the sagittal diameter of the spinal canal or in whom sequestrated fragments were seen on MRI will also be excluded.

Other exclusion criteria will include:

• Previous back surgeries

• Presence of any other concurrent foot pathology besides leg and low back pain and associated single level disc injury

• Nervous system problems (e.g., stroke, dementia, seizures)

• Cognitive dysfunction (e.g. TBI, CVA, Alzheimer's)

• Uncontrolled cardiovascular disease

• Evidence of cord compression

• Uncontrolled hypertension

• Infection

• Severe respiratory disease

• Pregnancy

• Rheumatic joint disease

• Peripheral vascular disease with sensory loss of the foot

• Any condition that the subject identifies that might limit participation in physical activity

Related Conditions & MeSH terms

• Low Back Disorder

Intervention

Procedure:
• Other: Exercise
exercise 3 times per week for 12 weeks

Locations

Country	Name	City	State
United States	University of Southern California	Los Angeles	California

Sponsors (1)

Lead Sponsor	Collaborator
University of Southern California

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	ODI		pre and post intervention